About Endece
Endece’s concept for the treatment of disease is to develop drugs that impact key molecular switches to alter biological pathways that control disease progression. Using our BioSwitch Concept™ approach, the initial focus is treating cancer by impacting switches that move multiple pathways from cell survival to cell death.
The virtual corporate structure allows Endece to maximize outcomes and efficiencies. By contracting with exceptional companies respected for their expertise in scientific research and regulatory and business practices, we rapidly progress the development of our novel compounds.
Endece’s corporate headquarters are located just 20 minutes north of Milwaukee in Mequon, Wisconsin.
